Lincoln Pharmaceuticals Ltd: Financial Statements & Historical Data

Lincoln Pharmaceuticals Ltd: For the quarter ending Jun 2026, reported sales were ₹177 crore and the net profit was ₹36 crore. Sales rose 14.9% and profit rose 28.6% against Jun 2025. Operating margin eased to 14.6% in Mar 2026.

Calculated from the stored statements below · Reporting periods remain separate

COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 9 October 2026, 9:00 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price558₹ per share

Reported P/E11.6Times

Book value per share378₹ per share

Reported ROCE16.3 %Reported return

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

All market & accounting figures

Stored market and accounting figures

Price record: 9 October 2026, 9:00 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	1,121 Cr.
Current Price	558
High / Low	770/440
Stock P/E	11.6
Book Value	378
Dividend Yield	0.32 %
ROCE	16.3 %
ROE	12.3 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

EARNINGS

Quarterly performance

Jun 2026

For the quarter ending Jun 2026, reported sales were ₹177 crore and the net profit was ₹36 crore. Sales rose 14.9% and profit rose 28.6% against Jun 2025. Operating margin was 15.3%, 0.3 percentage points lower than Jun 2025. The business retained less operating profit from each rupee of sales; review the expense mix in the statement.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	136	156	146	142	147	161	147	168	154	163	166	187	177
Expenses	115	125	117	124	125	133	123	141	130	138	143	162	150
Operating Profit	21	31	30	18	23	28	24	27	24	25	24	25	27
OPM %	15%	20%	20%	13%	15%	18%	16%	16%	15%	16%	14%	13%	15%
Other Income	8	9	11	7	10	10	9	-7	15	7	15	-4	24
Interest	0	0	0	0	0	0	1	0	0	0	0	0	0
Depreciation	3	3	3	3	3	3	3	3	3	4	4	4	4
Profit before tax	25	37	38	22	29	35	29	16	35	29	35	17	48
Tax %	25%	25%	26%	16%	20%	24%	28%	29%	22%	31%	18%	30%	24%
Net Profit	19	28	28	19	24	26	21	12	28	20	29	12	36
EPS in Rs	9.49	13.80	14.00	9.29	11.82	13.15	10.37	5.78	13.82	9.98	14.28	5.81	18.09

Last Updated: September 29, 2026, 7:17 pm

EARNINGS

Annual performance

Mar 2026

For the year ending Mar 2026, reported sales were ₹671 crore and the net profit was ₹88 crore. Sales rose 7.7% and profit rose 7.3% against Mar 2025. Operating margin was 14.6%, 1.8 percentage points lower than Mar 2025. The business retained less operating profit from each rupee of sales; review the expense mix in the statement.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 3:32 am

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	266	400	360	361	366	386	424	472	510	581	623	671	694
Expenses	240	359	313	308	299	321	337	376	421	480	522	573	593
Operating Profit	26	41	47	53	68	66	87	96	90	100	102	98	101
OPM %	10%	10%	13%	15%	18%	17%	21%	20%	18%	17%	16%	15%	15%
Other Income	7	7	2	5	5	11	5	10	22	34	22	33	42
Interest	8	10	7	5	4	2	2	1	2	1	2	1	1
Depreciation	5	5	6	6	7	7	8	8	9	11	13	14	15
Profit before tax	20	33	37	46	62	67	84	96	100	122	109	116	128
Tax %	24%	28%	25%	25%	22%	23%	26%	28%	27%	24%	25%	24%
Net Profit	15	24	28	35	49	51	62	69	73	93	82	88	96
EPS in Rs	9.20	14.52	14.06	17.31	24.36	25.72	31.12	34.63	36.40	46.58	41.11	43.88	48.16
Dividend Payout %	11%	7%	9%	9%	6%	6%	5%	4%	4%	4%	4%	4%

Earnings per share history

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Year-on-year profit growth table

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	60.00%	16.67%	25.00%	40.00%	4.08%	21.57%	11.29%	5.80%	27.40%	-11.83%	7.32%
Change in YoY Net Profit Growth (%)	0.00%	-43.33%	8.33%	15.00%	-35.92%	17.49%	-10.28%	-5.49%	21.60%	-39.23%	19.15%

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	10%
3 Years:	10%
TTM:	6%

Compounded Profit Growth
10 Years:	19%
5 Years:	10%
3 Years:	6%
TTM:	-12%

Stock Price CAGR
10 Years:	16%
5 Years:	18%
3 Years:	25%
1 Year:	-29%

Return on Equity
10 Years:	17%
5 Years:	16%
3 Years:	15%
Last Year:	13%

Last Updated: September 5, 2025, 9:50 am

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹4.00 crore in Mar 2026. They increased from ₹0.00 crore in Mar 2025. Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 27, 2026, 9:07 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	20	20	20	20	20	20	20	20	20	20
Reserves	95	124	172	204	249	293	346	413	482	573	652	738
Borrowings	76	78	64	61	34	5	1	2	2	1	0	4
Other Liabilities	70	56	48	62	63	71	85	99	83	106	125	128
Total Liabilities	258	275	305	347	366	389	452	534	587	700	797	890
Fixed Assets	66	98	103	117	121	123	111	132	151	179	182	191
CWIP	3	3	7	0	2	0	2	16	7	3	4	5
Investments	0	0	10	11	18	34	81	97	91	139	174	209
Other Assets	190	174	186	219	225	232	259	290	339	379	437	486
Total Assets	258	275	305	347	366	389	452	534	587	700	797	890

CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹106 crore in Mar 2026. Reported free cash flow for the same period was ₹82 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	25	45	25	27	53	75	69	76	39	63	93	106
Cash from Investing Activity +	7	-42	-25	-12	-18	-31	-64	-78	-37	-57	-79	-98
Cash from Financing Activity +	-32	-3	0	-11	-36	-38	-6	-3	-4	-5	-6	0
Net Cash Flow	-1	-0	-0	3	-1	7	-1	-4	-2	1	8	8
Free Cash Flow	21	11	7	17	38	68	61	31	26	24	74	82
CFO/OP	109%	126%	74%	68%	104%	137%	102%	104%	77%	89%	117%	135%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	21.00	11.00	7.00	17.00	38.00	68.00	61.00	31.00	26.00	24.00	74.00	82.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 217 in Mar 2025. That is 90 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	154	163	73	92	111	122	96	98	90	98	102	97
Inventory Days	62	44	36	63	86	75	95	86	121	106	101	99
Days Payable	174	92	40	54	82	92	102	105	120	77	95	106
Cash Conversion Cycle	43	116	70	100	115	106	88	78	91	126	108	90
Working Capital Days	13	76	31	69	89	113	126	119	113	121	127	217
ROCE %	11%	15%	21%	19%	19%	23%	22%	25%	24%	22%	22%	18%

Returns on capital & equity history

Returns on capital & equity

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 49.78% in Jun 2026. Their share was unchanged from Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction.

Shareholding comparison

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	50.53%	49.81%	49.54%	49.78%	49.78%	49.78%	49.78%	49.78%	49.78%	49.78%	49.78%	49.78%
FIIs	2.59%	3.22%	3.93%	3.95%	5.19%	5.16%	5.00%	5.13%	4.73%	4.70%	5.20%	4.60%
DIIs	0.00%	0.06%	0.05%	0.04%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	1.08%	0.27%
Public	46.87%	46.92%	46.49%	46.24%	45.04%	45.07%	45.23%	45.08%	45.49%	45.51%	43.94%	45.36%
No. of Shareholders	28,670	29,316	31,375	29,967	31,330	31,848	31,867	31,784	32,370	31,026	28,303	29,396

Shareholder count history

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Motilal Oswal S&P BSE Healthcare ETF	106	0.08	0.01	106	2025-04-22 17:25:28	0%

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Distributions & retention

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	41.11	46.58	36.40	34.63	31.11
Diluted EPS (Rs.)	41.11	46.58	36.40	34.63	31.11
Cash EPS (Rs.)	47.55	51.89	40.97	38.66	34.91
Book Value[Excl.RevalReserv]/Share (Rs.)	335.34	295.98	250.86	216.12	187.85
Book Value[Incl.RevalReserv]/Share (Rs.)	335.34	295.98	250.86	216.12	187.85
Revenue From Operations / Share (Rs.)	311.15	289.84	254.78	235.71	212.09
PBDIT / Share (Rs.)	61.89	67.07	55.76	52.66	46.42
PBIT / Share (Rs.)	55.45	61.76	51.18	48.62	42.64
PBT / Share (Rs.)	54.51	61.03	50.16	47.90	41.86
Net Profit / Share (Rs.)	41.11	46.58	36.40	34.63	31.12
NP After MI And SOA / Share (Rs.)	41.11	46.58	36.40	34.63	31.11
PBDIT Margin (%)	19.89	23.13	21.88	22.34	21.88
PBIT Margin (%)	17.82	21.30	20.08	20.62	20.10
PBT Margin (%)	17.51	21.05	19.68	20.32	19.73
Net Profit Margin (%)	13.21	16.07	14.28	14.69	14.67
NP After MI And SOA Margin (%)	13.21	16.07	14.28	14.69	14.66
Return on Networth / Equity (%)	12.25	15.73	14.50	16.02	16.58
Return on Capital Employeed (%)	16.07	20.34	19.89	21.94	22.10
Return On Assets (%)	10.33	13.32	12.41	12.97	13.54
Asset Turnover Ratio (%)	0.83	0.90	0.90	0.95	0.99
Current Ratio (X)	4.71	4.84	5.08	3.90	4.17
Quick Ratio (X)	3.97	4.00	4.11	3.10	3.53
Inventory Turnover Ratio (X)	8.00	7.89	2.48	2.66	2.18
Dividend Payout Ratio (NP) (%)	4.37	3.22	4.12	4.32	0.00
Dividend Payout Ratio (CP) (%)	3.78	2.89	3.66	3.87	0.00
Earning Retention Ratio (%)	95.63	96.78	95.88	95.68	0.00
Cash Earning Retention Ratio (%)	96.22	97.11	96.34	96.13	0.00
Interest Coverage Ratio (X)	65.84	91.70	55.01	72.68	59.44
Interest Coverage Ratio (Post Tax) (X)	44.74	64.69	36.91	48.79	40.86
Enterprise Value (Cr.)	1082.31	1159.77	646.08	574.49	436.11
EV / Net Operating Revenue (X)	1.74	2.00	1.27	1.22	1.03
EV / EBITDA (X)	8.73	8.63	5.79	5.45	4.70
MarketCap / Net Operating Revenue (X)	1.77	2.02	1.33	1.32	1.06
Retention Ratios (%)	95.62	96.77	95.87	95.67	0.00
Price / BV (X)	1.64	1.98	1.35	1.44	1.20
Price / Net Operating Revenue (X)	1.77	2.02	1.33	1.32	1.06
EarningsYield	0.07	0.07	0.10	0.11	0.13

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lincoln Pharmaceuticals Ltd	1,121 Cr.	558	770/440	11.6	378	0.32 %	16.3 %	12.3 %	10.0
Kopran Ltd	1,215 Cr.	251	296/107	48.6	110	1.19 %	6.65 %	4.91 %	10.0
Themis Medicare Ltd	995 Cr.	109	141/65.0		43.3	0.46 %	2.74 %	0.41 %	1.00
Bafna Pharmaceuticals Ltd	973 Cr.	418	425/94.8	125	40.6	0.00 %	11.9 %	12.3 %	10.0
Kilitch Drugs (India) Ltd	847 Cr.	242	268/117	28.2	80.0	0.00 %	13.4 %	10.6 %	10.0
Industry Average	17,127.26 Cr	1,216.62		53.25	211.24	0.40%	26.16%	16.59%	6.06

All Competitor Stocks of Lincoln Pharmaceuticals Ltd